QUINIDINE - POTENT INHIBITION OF SPARTEINE AND DEBRISOQUINE OXIDATION INVIVO

被引：67

作者：

INABA, T

TYNDALE, RE

MAHON, WA

机构：

来源：

关键词：

D O I：

10.1111/j.1365-2125.1986.tb05251.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：199 / 200

页数：2

共 7 条

[1] EICHELBAUM M, 1984, FED PROC, V43, P2298
[2] INABA T, 1985, DRUG METAB DISPOS, V13, P443
[3] COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINE
INABA, T
VINKS, A
OTTON, SV
KALOW, W
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (03) : 394 - 399
[4] KALOW W, 1984, FED PROC, V43, P2326
[5] LEEMANN T, 1986, EUR J CLIN PHARM
[6] OXIDATION PHENOTYPE AND THE METABOLISM AND ACTION OF BETA-BLOCKERS
LENNARD, MS
[J]. KLINISCHE WOCHENSCHRIFT, 1985, 63 (07): : 285 - 292
[7] COMPETITIVE-INHIBITION OF SPARTEINE OXIDATION IN HUMAN-LIVER BY BETA-ADRENOCEPTOR ANTAGONISTS AND OTHER CARDIOVASCULAR DRUGS
OTTON, SV
INABA, T
KALOW, W
[J]. LIFE SCIENCES, 1984, 34 (01) : 73 - 80